English Korean Chinese
ホーム > 市場調査レポート > 医薬品 > 神経疾患 > 欧州のパーキンソン病治療市場
カテゴリ
医薬品 (4964)
OTC (153)
がん (943)
ドラッグデリバリー (185)
ワクチン (181)
感染症 (353)
規制環境 (132)
後発医薬品 (135)
骨疾患 (37)
処方薬 (158)
神経疾患 (174)
精神疾患 (89)
製薬企業関連 (531)
創薬 (1524)
糖尿病 (193)
動物用医薬 (17)
肥満症 (44)
市場調査レポート

欧州のパーキンソン病治療市場

European Markets for Parkinson's Disease Therapeutics

発行 Frost & Sullivan
出版日 2009年05月 商品コード 90173
ページ情報 英文 71 Pages
価格
US$ 6,500 換算 ¥ 523,055 (税抜) Web Access (Regional License)
US$ 7,000 換算 ¥ 563,290 (税抜) Hard Copy & Web Access (Regional License)


原文目次

Abstract

This research service discusses the market for Parkinson' s disease. It analyses the various opportunities, recent developments, drug classes and gives a revenue forecasts.

Table of Contents

1. EXECUTIVE SUMMARY

Summary of Findings

  • Summary

2. PARKINSON' S DISEASE

Disease Overview

  • Scope
  • Overview
  • Prevalence and Incidence
  • Clinical Classification
  • Diagnosis

Treatment Overview

  • Guidelines for Parkinson' s Disease Management
  • Surgical and Related Options
  • Product and Pricing Analysis

3. MARKET FOR PARKINSON' S DISEASE THERAPEUTICS

Market Engineering Analysis

  • Market Overview
  • Market Engineering Measurements

Market Dynamics

  • Challenges
  • Market Drivers
  • Market Restraints

Market Forecasts and Trends

  • Disease Progression
  • Developments
  • Patient Forecasts
  • Revenue Forecasts

4. DOPAMINE AGONISTS MARKET

Current Drugs

  • Dosage and Pricing Analysis
  • Product Analysis

Market Dynamics

  • Market Drivers
  • Market Restraints

5. LEVODOPA/CARBIDOPA MARKET

Current Drugs

  • Dosage and Pricing Analysis
  • Product Analysis

Market Dynamics

  • Market Drivers
  • Market Restraints

6. OTHERS

Current Products and Pricing

  • COMT Inhibitors
  • MAO-B Inhibitors
  • Fixed Dose Combinations

Market Dynamics

  • Market Drivers
  • Market Restraints

Pipeline Analysis

  • Products in Phase III
  • Products in Phase II

7. DECISION SUPPORT DATABASES

List of Tables

  • Population Aged 65 Years and above
  • Female Population Aged 65 Years and above
  • Male Population Aged 65 Years and above
  • Number of Physicians
  • Hospital Discharge from Cerebrovascular Disease
Back to Top